--- title: "Weighing the Costs: How GLP-1 Weight Loss Drugs Can Save Employers Money in the Long Run" description: Discover how GLP-1 weight loss drugs can reduce obesity-related health costs, improve productivity, and save employers money in the long run. image: https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_717197856%20(1)-1.jpeg --- [Skip to content](https://blog.valenzhealth.com/weighing-the-costs-how-glp-1-weight-loss-drugs-can-save-employers-money-in-the-long-run#page-content) [![Valenz Health](https://blog.valenzhealth.com/hubfs/web/logo.svg)](https://www.valenzhealth.com/) - [Who We Serve](https://www.valenzhealth.com/who-we-serve/) - [Solutions](https://www.valenzhealth.com/solutions/member-experience/) - [About Us](https://www.valenzhealth.com/about-us/) - [Resources](https://www.valenzhealth.com/resources/) - [Contact](https://www.valenzhealth.com/contact/) ### [Patients](https://www.valenzhealth.com/who-we-serve/members/) ### Payers - [Employers](https://www.valenzhealth.com/who-we-serve/employers/) - [Taft-Hartley Funds](https://www.valenzhealth.com/who-we-serve/taft-hartley-funds/) ### Providers - [Healthcare Facilities and Providers](https://www.valenzhealth.com/who-we-serve/healthcare-facilities-and-providers/) ### Plans - [Health Plans](https://www.valenzhealth.com/who-we-serve/health-plans/) - [Third-Party Administrators](https://www.valenzhealth.com/who-we-serve/third-party-administrators-tpas/) - [Brokers and Consultants](https://www.valenzhealth.com/who-we-serve/brokers/) - [Stop Loss Producers](https://www.valenzhealth.com/who-we-serve/stop-loss-producers/) #### Partner with Us Discover how Vālenz Health® can simplify the healthcare experience with our innovative solutions. [Explore All](https://www.valenzhealth.com/who-we-serve/) ### Member Experience - [Overview](https://www.valenzhealth.com/solutions/member-experience/) - [Clinical Engagement](https://www.valenzhealth.com/solutions/member-experience/clinical-engagement/) - [Valenz Bluebook](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/) - - [Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) - [Surgical and Imaging](https://www.valenzhealth.com/solutions/member-experience/surgical-imaging/) - [Infusion Therapy](https://www.valenzhealth.com/solutions/member-experience/infusion-therapy/) ### Payment Integrity - [Overview](https://www.valenzhealth.com/solutions/payment-integrity/) - [ABN Medical Necessity](https://www.valenzhealth.com/solutions/payment-integrity/abn-medical-necessity-validation/) - [Clean Claim Verification](https://www.valenzhealth.com/solutions/payment-integrity/clean-claim-verification/) - [Bill Review](https://www.valenzhealth.com/solutions/payment-integrity/clinical-bill-review/) - [Curated Data Sources](https://www.valenzhealth.com/solutions/payment-integrity/curated-data-sources/) - [In-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/in-network-repricing/) - [Out-of-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/out-of-network-repricing/) ### Provider Quality - [Overview](https://www.valenzhealth.com/solutions/provider-quality/) - [Credentialing](https://www.valenzhealth.com/solutions/provider-quality/credentialing/) - [Provider Staff Sanction Monitoring](https://www.valenzhealth.com/solutions/provider-quality/provider-staff-sanction-monitoring/) - [CareChex® Awards](https://www.valenzhealth.com/solutions/provider-quality/carechex-awards-by-quantros/) - [Outcomes Analytics by Quantros](https://www.valenzhealth.com/solutions/provider-quality/outcomes-analytics/) ### Plan Performance - [Overview](https://www.valenzhealth.com/solutions/plan-performance/) - [Stop Loss](https://www.valenzhealth.com/solutions/plan-performance/stop-loss/) - [Variable Copay](https://www.valenzhealth.com/solutions/plan-performance/variable-copay/) ### Platform - [Integrated Platform](https://www.valenzhealth.com/solutions/integrated-platform/) #### Solution Finder Find the right solution for your needs. [Get Started](https://www.valenzhealth.com/solutions/) ### Company - [About Valenz Health](https://www.valenzhealth.com/about-us/) - [Careers](https://www.valenzhealth.com/about-us/careers/) ### Why Valenz - [Leadership Team](https://www.valenzhealth.com/about-us/#Executive-Leadership) - [Our Mission](https://www.valenzhealth.com/about-us/#About-Valenz-Health) - [Our Values](https://www.valenzhealth.com/about-us/#Core-Values) #### Join Our Team Be part of the healthcare revolution. We're hiring talented individuals who share our vision. [View Open Positions](https://www.valenzhealth.com/about-us/careers/) ### Regulatory & Compliance - [The No Surprises Act (NSA)](https://www.valenzhealth.com/resources/no-surprises-act/) - [Transparency in Coverage (TiC)](https://www.valenzhealth.com/resources/transparency-in-coverage/) - [OIG Compliance](https://www.valenzhealth.com/resources/oig-compliance/) ### Industry Insights - [Fighting Fraud, Waste, and Abuse](https://www.valenzhealth.com/resources/fraud-waste-abuse/) - [Self-Funded Insurance](https://www.valenzhealth.com/resources/self-funded-health-insurance/) #### Resource Center Stay informed with our latest whitepapers, guides, and industry insights. [Browse All Resources](https://www.valenzhealth.com/resources/) [![Valenz Health](https://blog.valenzhealth.com/hubfs/web/logo.svg)](https://www.valenzhealth.com/) - Who We Serve - Solutions - About Us - Resources - Contact Us - Login - Search Back ### Who We Serve - [Overview](https://www.valenzhealth.com/who-we-serve/) #### Patients - [Members](https://www.valenzhealth.com/who-we-serve/members/) #### Payers - [Employers](https://www.valenzhealth.com/who-we-serve/employers/) - [Taft-Hartley Funds](https://www.valenzhealth.com/who-we-serve/taft-hartley-funds/) #### Providers - [Healthcare Facilities and Providers](https://www.valenzhealth.com/who-we-serve/healthcare-facilities-and-providers/) #### Plans - [Health Plans](https://www.valenzhealth.com/who-we-serve/health-plans/) - [Third-Party Administrators](https://www.valenzhealth.com/who-we-serve/third-party-administrators-tpas/) - [Brokers and Consultants](https://www.valenzhealth.com/who-we-serve/brokers/) - [Stop Loss Producers](https://www.valenzhealth.com/who-we-serve/stop-loss-producers/) Back ### Solutions - [Overview](https://www.valenzhealth.com/solutions/) - [Member Experience](https://www.valenzhealth.com/solutions/member-experience/) - [Payment Integrity](https://www.valenzhealth.com/solutions/payment-integrity/) - [Provider Quality](https://www.valenzhealth.com/solutions/provider-quality/) - [Plan Performance](https://www.valenzhealth.com/solutions/plan-performance/) - [Platform](https://www.valenzhealth.com/solutions/integrated-platform/) Back ### About Us - [Overview](https://www.valenzhealth.com/about-us/) - [Careers](https://www.valenzhealth.com/about-us/careers/) Back ### Resources - [Overview](https://www.valenzhealth.com/resources/) - [The No Surprises Act (NSA)](https://www.valenzhealth.com/resources/no-surprises-act/) - [Transparency in Coverage (TiC)](https://www.valenzhealth.com/resources/transparency-in-coverage/) - [Office of Inspector General Compliance](https://www.valenzhealth.com/resources/oig-compliance/) - [Fighting Fraud, Waste, and Abuse (FWA)](https://www.valenzhealth.com/resources/fraud-waste-abuse/) - [Self-Funded Insurance](https://www.valenzhealth.com/resources/self-funded-health-insurance/) Back ### Payment Integrity - [Overview](https://www.valenzhealth.com/solutions/payment-integrity/) - [ABN Medical Necessity Validation](https://www.valenzhealth.com/solutions/payment-integrity/abn-medical-necessity-validation/) - [Clean Claim Verification](https://www.valenzhealth.com/solutions/payment-integrity/clean-claim-verification/) - [Bill Review](https://www.valenzhealth.com/solutions/payment-integrity/clinical-bill-review/) - [Curated Data Sources](https://www.valenzhealth.com/solutions/payment-integrity/curated-data-sources/) - [In-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/in-network-repricing/) - [Out-of-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/out-of-network-repricing/) Back ### Provider Quality - [Overview](https://www.valenzhealth.com/solutions/provider-quality/) - [Credentialing](https://www.valenzhealth.com/solutions/provider-quality/credentialing/) - [Provider Staff Sanction Monitoring](https://www.valenzhealth.com/solutions/provider-quality/provider-staff-sanction-monitoring/) - [CareChex® Awards by Quantros](https://www.valenzhealth.com/solutions/provider-quality/carechex-awards-by-quantros/) - [Outcomes Analytics by Quantros](https://www.valenzhealth.com/solutions/provider-quality/outcomes-analytics/) Back ### Member Experience - [Overview](https://www.valenzhealth.com/solutions/member-experience/) - [Clinical Engagement](https://www.valenzhealth.com/solutions/member-experience/clinical-engagement/) - [Valenz Bluebook](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/) - [• Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) - [Precision Care](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/#precision-care/) Back ### Plan Performance - [Overview](https://www.valenzhealth.com/solutions/plan-performance/) - [Stop Loss](https://www.valenzhealth.com/solutions/plan-performance/stop-loss/) - [Variable Copay](https://www.valenzhealth.com/solutions/plan-performance/variable-copay/) Back ### Search # Weighing the Costs: How GLP-1 Weight Loss Drugs Can Save Employers Money in the Long Run By [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) - January 30, 2025 [Pharmacy and Prescription Drugs](https://blog.valenzhealth.com/tag/pharmacy-and-prescription-drugs) [GLP-1s](https://blog.valenzhealth.com/tag/glp-1s) Share ![A female patient holding an injection.](https://blog.valenzhealth.com/hs-fs/hubfs/Blog/AdobeStock_717197856%20(1)-1.jpeg?width=485&height=485&name=AdobeStock_717197856%20(1)-1.jpeg) The popularity of glucagon-like peptide-1 (GLP-1) weight loss drugs is on the rise, offering transformative health benefits for those struggling with obesity. For employers, these medications present a unique opportunity to improve employee well-being while addressing the substantial financial implications of chronic health conditions.  That said, the high costs of GLP-1 drugs raise questions about how to balance immediate expenses with long-term savings. The truth is, while [GLP-1 weight loss drugs](https://blog.valenzhealth.com/navigating-the-world-of-glp-1s-key-insights-for-employers) are costly, their potential to reduce both obesity-related illnesses and overall healthcare costs can create significant value for employers committed to workforce health. Solutions like those offered by  Vālenz Health® can help employers make informed decisions to manage costs while improving health outcomes. ## Positive Impacts of GLP-1 Weight Loss Drug Coverage Employers who invest in their workforce’s health stand to gain more than just a healthier team. They also unlock key operational benefits, such as: ### Reduced Absenteeism GLP-1 weight loss drugs help employees achieve and maintain a healthy weight. These medications also improve their ability to [manage chronic conditions](https://blog.valenzhealth.com/complex-healthcare-needs), such as diabetes and hypertension. With better health, employees [experience fewer sick days](https://reba.global/resource/unum-research-health-happiness-and-productivity.html), reducing absenteeism and the costs associated with lost productivity. ### Lower Healthcare Costs Obesity contributes to several chronic illnesses, which often result in substantial healthcare expenses. By promoting weight loss, GLP-1 drugs can help mitigate these conditions, leading to fewer medical claims and reduced healthcare spending for both employers and employees. ### Higher Employee Satisfaction Employers that offer GLP-1 coverage demonstrate a commitment to employee health and well-being, which can, in turn, boost morale and satisfaction. [Research shows](https://reba.global/resource/unum-research-health-happiness-and-productivity.html) that healthier, happier employees are more engaged, productive, and loyal, which creates a ripple effect of benefits across the organization. ## Challenges of Covering GLP-1 Weight Loss Drugs While the benefits of GLP-1 medications are promising, their adoption isn’t without hurdles. Employers are tasked with weighing these advantages against challenges such as: ### High Up-Front Costs The price of GLP-1 drugs often exceeds [$1,000 a month](https://www.businessinsider.com/doctor-how-patients-afford-glp-1-weight-loss-drugs-2024-9) per patient. For employers, offering GLP-1 weight loss coverage can increase the organization’s healthcare expenses, initially straining benefits budgets. Employers may need to raise insurance premiums to offset the costs of GLP-1 coverage, and while these adjustments can help manage expenses, they can also impact employees’ out-of-pocket costs and overall satisfaction. ### Patient Adherence Research shows that many patients stop taking GLP-1 weight loss drugs [due to cost and side effects](https://www.healthcentral.com/news/obesity/6-revealing-things-you-told-us-about-the-latest-obesity-meds), which can ultimately lead to weight regain. This pattern of patient nonadherence raises concerns about the return on investment for employers covering these medications. ### Long-Term Contracts For some patients, GLP-1 drugs require long-term use to maintain results. Sustaining these prescriptions over extended periods can create financial challenges for both employers and employees. ## Strategies to Help Manage the Costs of GLP-1 Drugs To maximize the value of GLP-1 coverage and help with [managing costs](https://blog.valenzhealth.com/balancing-the-scales-the-financial-implications-of-glp-1-drugs-for-employers), employers can implement thoughtful strategies that make these medications more accessible and affordable. Some proven approaches include: ### Utilization Management Employers can implement measures such as prior authorization, ensuring GLP-1 prescriptions are reserved for employees who meet specific clinical criteria, such as those with a high body mass index or related chronic conditions, such as diabetes or hypertension. This approach promotes responsible use and minimizes unnecessary costs. ### Bundling Benefits Integrating GLP-1 coverage with broader health and wellness programs can make these medications more affordable for employers and employees alike. For instance, bundling weight loss drugs with diabetes management services may provide added value while also reducing overall costs. ### Patience Assistance Employers can partner with pharmaceutical companies to access patient assistance programs, which often provide discounts or subsidies. These programs make GLP-1 drug coverage more attainable and sustainable across the board. ## How Vālenz Health® Can Help with GLP-1 Weight Loss Drug Coverage Navigating the complexities of [GLP-1 drug coverage](https://blog.valenzhealth.com/investing-in-health-employer-coverage-of-glp-1-weight-loss-drugs) can be daunting, but employers don’t have to face these challenges alone. [Valenz Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) helps employers reduce pharmacy spend while improving employee well-being. This innovative solution engages members and leverages data analysis to identify savings opportunities.  By combining medical and pharmacy navigation into one unique platform, Valenz Bluebook Rx empowers employers to maximize the value of their healthcare investment. Unlock your potential savings by contacting our team today. ### Connect with Us to Learn More   ![Vālenz Health®](https://blog.valenzhealth.com/hs-fs/hubfs/Valenz%20Logo%20Signature.png?width=48&height=48&name=Valenz%20Logo%20Signature.png) [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) Vālenz Health® empowers employers, brokers, payers, and providers to reduce costs, improve quality, and elevate the healthcare experience. Our solutions combine advanced technology, clinical expertise, and extensive cost, quality, and utilization datasets to execute across the entire healthcare journey — connecting insights and action for greater transparency, flexibility, and cost containment within a complex system. By helping our customers and members navigate healthcare with confidence, we support smarter care decisions, strengthen plan performance, and deliver better value for everyone we serve. ## Related Articles [![A woman with a chronic health condition takes medication while sitting at a desk. ](https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_600720024%20(1)-1.jpeg)](https://blog.valenzhealth.com/health-conditions-driving-up-healthcare-costs) ### [The Health Conditions Driving Up Healthcare Costs — and What Employers Can Do About Them](https://blog.valenzhealth.com/health-conditions-driving-up-healthcare-costs) For the second year in a row, healthcare costs are expected to rise by 9% for the group market in the United States, according to the latest research by PWC. [Trista Taylor](https://blog.valenzhealth.com/author/trista-taylor) July 02, 2026 [![A group of employees meet in a conference room. ](https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_894584095%20(2)-1-1.jpeg)](https://blog.valenzhealth.com/glp-1-weight-loss-drugs-addressing-obesity-and-chronic-health-issues-in-the-workplace) ### [GLP-1 Weight Loss Drugs: Addressing Obesity and Chronic Health Issues in the Workplace](https://blog.valenzhealth.com/glp-1-weight-loss-drugs-addressing-obesity-and-chronic-health-issues-in-the-workplace) Many health issues arise from obesity, such as high blood pressure, diabetes, heart disease, heart failure, and other conditions. Addressing obesity and other chronic health issues is critical to improving employee health. Today, there are drugs, such as glucagon-like peptide-1 (GLP-1) receptor agonists, to help employees manage weight and their risk for chronic conditions. [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) January 11, 2025 Share Ready to Simplify Self-Insurance? ## Your Journey Starts Here Connect with a Valenz team member to explore the difference our solutions can make for you. ![Vālenz Health](https://www.valenzhealth.com/wp-content/uploads/2025/05/logo.svg) [![Youtube](https://www.valenzhealth.com/wp-content/uploads/2025/06/Icon-Youtube.svg)](https://www.youtube.com/@valenzhealth) [![Linkedin](https://www.valenzhealth.com/wp-content/uploads/2025/06/Icon-Linkedin.svg)](https://www.linkedin.com/company/valenz/) [Login](https://www.valenzhealth.com/user-login/) [Help Center](https://support.valenzhealth.com/hc/en-us) [Trust Center](https://trust.valenzhealth.com/) [Privacy Policy](https://www.valenzhealth.com/privacy-policy/) Cookie Settings [Cookie Policy](https://www.valenzhealth.com/cookie-policy/) [California Privacy Rights Notice](https://www.valenzhealth.com/california-privacy-rights-notice/) [Terms and Conditions](https://www.valenzhealth.com/terms-and-conditions/) 1717 McKinney Ave, Suite 1000, Dallas, TX 75202, USA | [(866) 762-4455](tel:+18667624455) © 2026 Vālenz Health® ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "about" : [ { "@type" : "Thing", "name" : "Pharmacy and Prescription Drugs" }, { "@type" : "Thing", "name" : "GLP-1s" } ], "articleBody" : "The popularity of glucagon-like peptide-1 (GLP-1) weight loss drugs is on the rise, offering transformative health benefits for those struggling with obesity. For employers, these medications present a unique opportunity to improve employee well-being while addressing the substantial financial implications of chronic health conditions. That said, the high costs of GLP-1 drugs raise questions about how to balance immediate expenses with long-term savings. The truth is, while GLP-1 weight loss drugs are costly, their potential to reduce both obesity-related illnesses and overall healthcare costs can create significant value for employers committed to workforce health. Solutions like those offered by Vālenz Health® can help employers make informed decisions to manage costs while improving health outcomes. Positive Impacts of GLP-1 Weight Loss Drug Coverage Employers who invest in their workforce’s health stand to gain more than just a healthier team. They also unlock key operational benefits, such as: Reduced Absenteeism GLP-1 weight loss drugs help employees achieve and maintain a healthy weight. These medications also improve their ability to manage chronic conditions, such as diabetes and hypertension. With better health, employees experience fewer sick days, reducing absenteeism and the costs associated with lost productivity. Lower Healthcare Costs Obesity contributes to several chronic illnesses, which often result in substantial healthcare expenses. By promoting weight loss, GLP-1 drugs can help mitigate these conditions, leading to fewer medical claims and reduced healthcare spending for both employers and employees. Higher Employee Satisfaction Employers that offer GLP-1 coverage demonstrate a commitment to employee health and well-being, which can, in turn, boost morale and satisfaction. Research shows that healthier, happier employees are more engaged, productive, and loyal, which creates a ripple effect of benefits across the organization. Challenges of Covering GLP-1 Weight Loss Drugs While the benefits of GLP-1 medications are promising, their adoption isn’t without hurdles. Employers are tasked with weighing these advantages against challenges such as: High Up-Front Costs The price of GLP-1 drugs often exceeds $1,000 a month per patient. For employers, offering GLP-1 weight loss coverage can increase the organization’s healthcare expenses, initially straining benefits budgets. Employers may need to raise insurance premiums to offset the costs of GLP-1 coverage, and while these adjustments can help manage expenses, they can also impact employees’ out-of-pocket costs and overall satisfaction. Patient Adherence Research shows that many patients stop taking GLP-1 weight loss drugs due to cost and side effects, which can ultimately lead to weight regain. This pattern of patient nonadherence raises concerns about the return on investment for employers covering these medications. Long-Term Contracts For some patients, GLP-1 drugs require long-term use to maintain results. Sustaining these prescriptions over extended periods can create financial challenges for both employers and employees. Strategies to Help Manage the Costs of GLP-1 Drugs To maximize the value of GLP-1 coverage and help with managing costs, employers can implement thoughtful strategies that make these medications more accessible and affordable. Some proven approaches include: Utilization Management Employers can implement measures such as prior authorization, ensuring GLP-1 prescriptions are reserved for employees who meet specific clinical criteria, such as those with a high body mass index or related chronic conditions, such as diabetes or hypertension. This approach promotes responsible use and minimizes unnecessary costs. Bundling Benefits Integrating GLP-1 coverage with broader health and wellness programs can make these medications more affordable for employers and employees alike. For instance, bundling weight loss drugs with diabetes management services may provide added value while also reducing overall costs. Patience Assistance Employers can partner with pharmaceutical companies to access patient assistance programs, which often provide discounts or subsidies. These programs make GLP-1 drug coverage more attainable and sustainable across the board. How Vālenz Health® Can Help with GLP-1 Weight Loss Drug Coverage Navigating the complexities of GLP-1 drug coverage can be daunting, but employers don’t have to face these challenges alone. Valenz Bluebook Rx helps employers reduce pharmacy spend while improving employee well-being. This innovative solution engages members and leverages data analysis to identify savings opportunities. By combining medical and pharmacy navigation into one unique platform, Valenz Bluebook Rx empowers employers to maximize the value of their healthcare investment. Unlock your potential savings by contacting our team today. Connect with Us to Learn More", "articleSection" : [ "Positive Impacts of GLP-1 Weight Loss Drug Coverage", "Reduced Absenteeism", "Lower Healthcare Costs", "Higher Employee Satisfaction", "Challenges of Covering GLP-1 Weight Loss Drugs", "High Up-Front Costs", "Patient Adherence", "Long-Term Contracts", "Strategies to Help Manage the Costs of GLP-1 Drugs", "Utilization Management", "Bundling Benefits", "Patience Assistance", "How Vālenz Health® Can Help with GLP-1 Weight Loss Drug Coverage" ], "author" : { "@id" : "https://blog.valenzhealth.com/author/valenz-health", "@type" : "Person", "name" : "Vālenz Health®", "url" : "https://blog.valenzhealth.com/author/valenz-health" }, "dateModified" : "2025-12-18T11:45:36-05:00", "datePublished" : "2025-01-30T09:00:00-05:00", "description" : "Discover how GLP-1 weight loss drugs can reduce obesity-related health costs, improve productivity, and save employers money in the long run.", "headline" : "Weighing the Costs: How GLP-1 Weight Loss Drugs Can Save Employers Money in the Long Run", "image" : "https://1769848.fs1.hubspotusercontent-na1.net/hubfs/1769848/Blog/AdobeStock_717197856%20%281%29-1.jpeg", "mainEntityOfPage" : { "@id" : "https://blog.valenzhealth.com/weighing-the-costs-how-glp-1-weight-loss-drugs-can-save-employers-money-in-the-long-run", "@type" : "WebPage" }, "publisher" : { "@id" : "https://www.valenzhealth.com/", "@type" : "Organization", "areaServed" : "United States of America (USA)", "contactPoint" : { "@type" : "ContactPoint", "areaServed" : "United States of America (USA)", "availableLanguage" : [ "English" ], "contactType" : "Customer Service", "email" : "info@valenzhealth.com", "telephone" : "866-762-4455", "url" : "https://www.valenzhealth.com/contact/" }, "logo" : { "@type" : "ImageObject", "url" : "https://blog.valenzhealth.com/hubfs/web/logo.svg" }, "name" : "Vālenz Health®", "sameAs" : [ "https://www.youtube.com/@valenzhealth", "https://www.linkedin.com/company/valenz/" ], "url" : "https://www.valenzhealth.com/" }, "url" : "https://blog.valenzhealth.com/weighing-the-costs-how-glp-1-weight-loss-drugs-can-save-employers-money-in-the-long-run", "wordCount" : 736 } ```